摘要
血清淀粉样蛋白A (serum amyloid A, SAA)是由肝脏产生的一组多肽脂蛋白,当机体受到炎性刺激并发生炎症反应时可迅速升高。对于新型冠状病毒肺炎、慢性阻塞性肺疾病急性加重、间质性肺疾病、肺结核、肺癌等呼吸系统疾病的早期诊断、指导治疗、疗效评估有重要的意义。现就SAA在呼吸系统疾病中的临床应用价值方面作一综述。
Serum amyloid A (serum amyloid A, SAA) is a group of polypeptide lipoproteins produced by the liver, which can be rapidly increased when the body receives inflammatory stimulation and devel-ops an inflammatory reaction. It is of great significance for the early diagnosis, guiding treatment and efficacy evaluation of respiratory diseases such as COVID-19, acute aggravation of chronic ob-structive pulmonary disease, interstitial lung disease, tuberculosis and lung cancer. The clinical ap-plication value of SAA in respiratory diseases is reviewed.
出处
《临床医学进展》
2023年第12期19117-19122,共6页
Advances in Clinical Medicine
